Long terminal repeat sequence analysis of HTLV-2 molecular variants identified in southern Brazil

AIDS Research and Human Retroviruses

Volumn 26, Issue 12, 2010, Pages 1327-1331

  Magri, Mariana Cavalheiro ^a,b   Morimoto, Helena Kaminami ^c   De MacEdo Brígido, Luis Fernando ^a   Rodrigues, Rosangela ^a   Caterino De Araujo, Adele ^a,b  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c STATE UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAZIL; CORRELATION ANALYSIS; GENETIC VARIABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN T CELL LEUKEMIA VIRUS 2; HUMAN T CELL LEUKEMIA VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONG TERMINAL REPEAT; MAXIMUM LIKELIHOOD METHOD; NEIGHBOR JOINING METHOD; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SEQUENCE ANALYSIS; SEXUAL BEHAVIOR; UNINDEXED SEQUENCE; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING;

BRAZIL; DNA FINGERPRINTING; GENOTYPE; HTLV-II INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 2; HUMANS; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; TERMINAL REPEAT SEQUENCES;

EID: 78650293079     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2010.0121     Document Type: Article

References (21)

1. Hall WW, Ishak R, Zhu SW, et al.: Human T lymphotropic virus type II (HTLV-II): Epidemiology, molecular properties, and clinical features of infection. J AIDS 1996;13:S204-S214.
2. Murphy EL, Mahieux R, de Thé G, et al.: Molecular epide-miology of HTLV-II among United States blood donors and intravenous drug user: An age-cohort effect for HTLV-II RFLP type a0. Virology 1998;242:425-434.
3. Black FL, Biggar RJ, Neel JV, Maloney EM, and Waters DJ: Endemic transmission of HTLV type II among Kayapo In-dians of Brazil. AIDS Res Hum Retrovir 1994;10:1165-1171.
4. Ishak MQ Ishak R, Vallinoto ACR, Azevedo VN, and Ishak MQ: Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil. Cad Saúde Pública, Rio de Janeiro 2003;19:901-914.
5. Menna-Barreto M, Bender AL, Bonatto SL, et al.: Human T-cell lymphotropic virus type II in Guarań? Indians, Southern Brazil. Cad Saúde Pública, Rio de Janeiro 2005;21:1947-1951.
6. Gabbai AA, Bordini JO, Vieira-Filho JPB, et al.: Selectivity of human T lymphotropic v́?rus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg 1993;49:664-671.
7. Catalan-Soares B, Carneiro-Proietti AB, Proietti FA, and In-terdisciplinary HTLV Research Group: Heterogeneous geo-graphic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban area in Brazil. Cad Saúde Pública, Rio de Janeiro 2005;21:926-931.
8. Namen-Lopes MSS, Martins ML, Drummond PC, Lobato RR, Interdisciplinary HTLV Research Group, and Carneiro-Proietti ABF: Lookback study of HTLV-1 and 2 seropositive donors and their recipients in Belo Horizonte, Brazil. Transfusion Med 2009;19:180-188.
9. De-Araujo AC, Casseb JSR, Neitzer E, et al.: HTLV-I and HTLV-II infections among HIV-1 seropositive patients in São Paulo, Brazil. Eur J Epidemiol 1994;10:165-171.
10. Etzel A, Shibata GY, Rozman M, Jorge MLSG, Damas CD, and Segurado AAC: HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: Seroprevalence and risk factors. J AIDS 2001;26:185-190.
11. Morimoto HK, Caterino-de-Araujo A, Morimoto AA, et al.: Seroprevalence and risk factors for human T-cell lympho-tropic virus type 1 and 2 infection in human immunodefi-ciency virus (HIV)-infected patients attending AIDS Referral Center Health Units in Londrina and other communities in Paraná, Brazil. AIDS Res Hum Retrovir 2005;21:256-262.
12. Lewis MJ, Novoa P, Ishak R, et al.: Isolation, cloning, and complete sequence of a phenotypically distinct Brazilian isolate of human T-lymphotropic virus type II (HTLV-II). Virology 2000;271:142-154.
13. Shindo N, Alcantara LCJ, Van Dooren S, et al.: Human ret-roviruses (HIV and HTLV) in Brazilian Indians: Seroepi-demiological study and molecular epidemiology of HTLV type 2 isolates. AIDS Res Hum Retrovir 2002;18:71-77.
14. Covas DM, and Kashima S: Complete nucleotide sequences of the genomes of two Brazilian specimens of human T lymphotropic virus type 2 (HTLV-2). AIDS Res Hum Retrovir 2003;19:689-697.
15. Alcântara LCJ, Shindo N, Van Doren S, et al.: Brazilian HTLV type 2a strains from intravenous drug users (IDUs) appear to have originated from two sources: Brazilian Am-erindians and European/North American IDUs. AIDS Res Hum Retrovir 2003;19:519-523.
16. Renner JDP, Laurino JP, Menna-Barreto M, and Schmitt VM: Molecular evidence of HTLV-II subtype B among an urban population living in South Brazil. AIDS Res Hum Retrovir 2006;22:301-306.
17. Novoa P, Penalva de Oliveira AC, Posada-Vergara MP, Duarte AJS, and Casseb J: Molecular characterization of human T-cell lymphotropic virus type 2 (HTLV-II) from people living in urban areas of Sao Paulo city: Evidence of multiple subtypes circulation. J Med Virol 2007; 79:182-187.
18. Morimoto HK, Morimoto AA, Reiche EMV, et al.: Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil: Comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev Inst Med Trop S Paulo 2007;49:225-230.
19. Switzer WM, Pieniazek D, Swanson P, et al.: Phylogenetic relationship and geographic distribution of multiple human T-cell lymphotropic virus type II subtypes. J Virol 1995;69: 621-632.
20. Eiraku V, Monken C, Kubo T, et al.: Nucleotide sequence and restriction fragment length polymorphism analysis of the long terminal repeat of human T cell leukemia virus type II. AIDS Res Hum Retrovir 1995;11:625-636.
21. Salemi M, Lewis M, Egan JF, Hall WW, Desmyter J, and Vandamme A-M: Different population dynamics of human T-cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes. Proc Natl Acad Sci USA 1999:96:13253-13258.